16.3 Immune engineering and synthetic immunology
3 min read•july 25, 2024
Immune engineering merges immunology with bioengineering to enhance immune functions. It aims to boost responses against pathogens and tumors, while suppressing unwanted reactions in autoimmune diseases. This field develops better vaccines and tailors treatments to individual patients.
Synthetic immunology applies synthetic biology to create artificial immune components. It enables precise control over function and specificity, allowing for customizable immune responses. Applications include engineered , synthetic , and programmable immune cells for targeted therapies.
Fundamentals of Immune Engineering and Synthetic Immunology
Goals of immune engineering
Top images from around the web for Goals of immune engineering
Frontiers | Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation View original
Is this image relevant?
Frontiers | Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions ... View original
Is this image relevant?
Frontiers | Using Gene Editing Approaches to Fine-Tune the Immune System View original
Is this image relevant?
Frontiers | Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation View original
Is this image relevant?
Frontiers | Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions ... View original
Is this image relevant?
1 of 3
Top images from around the web for Goals of immune engineering
Frontiers | Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation View original
Is this image relevant?
Frontiers | Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions ... View original
Is this image relevant?
Frontiers | Using Gene Editing Approaches to Fine-Tune the Immune System View original
Is this image relevant?
Frontiers | Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation View original
Is this image relevant?
Frontiers | Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions ... View original
Is this image relevant?
1 of 3
- Immune engineering combines immunology, bioengineering, and molecular biology to manipulate and enhance immune system functions
- Enhance immune responses against pathogens and tumors through targeted activation strategies ()
- Suppress unwanted immune reactions in autoimmune diseases and transplantation using immunomodulatory approaches (regulatory T cells)
- Develop more effective vaccines and immunotherapies by optimizing and immune cell activation (mRNA vaccines)
- Create precision medicine approaches tailoring treatments to individual patients' immune profiles (neoantigen vaccines)
- Modulation techniques employ genetic modification of immune cells, nanoparticle-based drug delivery systems, and biomaterial scaffolds for controlled immune cell activation
Principles of synthetic immunology
- Synthetic immunology applies synthetic biology principles to immunology creating artificial immune components and systems
- Rational design of immune components enables precise control over function and specificity ()
- Modular assembly of immune system parts allows for customizable and tunable immune responses ()
- Predictable and controllable immune responses achieved through engineered feedback loops and regulatory circuits
- Applications include engineered antibodies with enhanced specificity and efficacy, synthetic cytokines with improved pharmacokinetics, artificial antigen-presenting cells for T cell activation, and programmable immune cells for targeted therapies ()
Advanced Techniques and Considerations
Gene editing for immune cell engineering
- system acts as a programmable DNA-cutting tool allowing precise genetic modifications in immune cells
- Applications involve knockout of inhibitory receptors to enhance T cell function, introduction of chimeric antigen receptors (CARs) into T cells, and modification of cytokine production profiles
- Other tools include TALENs and Zinc Finger Nucleases (ZFNs) offering alternative approaches for genetic manipulation
- Gene editing in immune engineering increases precision and efficiency compared to traditional methods and enables creation of multiplex modifications
Potential of engineered immune cells
- CAR-T cell therapy engineers T cells to express chimeric antigen receptors targeting specific tumor antigens
- Remarkable success achieved in certain hematological malignancies (B-cell leukemias and lymphomas)
- Ongoing research explores applications for solid tumors and addresses challenges like off-target effects and cytokine release syndrome
- Other engineered immune cells include , , and macrophages enhanced for phagocytosis
- Potential applications extend beyond cancer to autoimmune diseases, infectious diseases, and regenerative medicine
Ethics of immune engineering
- Safety concerns for patients and society arise from potential long-term effects and unintended consequences of genetic modifications
- Equitable access to advanced therapies raises questions about healthcare disparities and resource allocation
- Regulatory challenges involve balancing innovation with safety, developing appropriate clinical trial designs, and harmonizing international regulations
- Societal implications include impact on healthcare costs, public perception, and acceptance of engineered immune therapies
- Intellectual property issues surrounding patenting of engineered immune components and therapies require balancing innovation incentives with public health needs
Key Terms to Review (22)
Antibodies: Antibodies are specialized proteins produced by the immune system to identify and neutralize foreign objects like bacteria, viruses, and toxins. They are critical components of the adaptive immune response, specifically generated by B cells in response to specific antigens, helping to provide long-term immunity against pathogens.
Antigen Presentation: Antigen presentation is the process by which immune cells display antigens on their surface to enable T cells to recognize and respond to pathogens or infected cells. This crucial mechanism bridges innate and adaptive immunity, allowing for a targeted immune response against specific threats.
Autoimmune disease management: Autoimmune disease management refers to the strategies and interventions used to control and treat autoimmune diseases, where the immune system mistakenly attacks the body's own cells. Effective management involves a combination of pharmacological therapies, lifestyle modifications, and patient education to alleviate symptoms and improve the quality of life for affected individuals. This field is rapidly evolving, particularly with advancements in immune engineering and synthetic immunology, which aim to tailor treatments that can specifically target dysfunctional immune responses.
B-cell reprogramming: B-cell reprogramming refers to the process of altering B cells' genetic programming or functional characteristics, enabling them to produce antibodies against specific antigens or perform other immune-related functions. This manipulation can enhance the immune response to pathogens, support therapeutic strategies for autoimmune diseases, and advance vaccine development through synthetic immunology and immune engineering techniques.
Bispecific antibodies: Bispecific antibodies are engineered proteins that can simultaneously bind to two different antigens or epitopes, making them versatile tools in therapeutic applications. By engaging two distinct targets, these antibodies can facilitate more effective immune responses against diseases such as cancer and autoimmune disorders. Their unique binding capability allows them to redirect immune cells to tumor cells or alter immune signaling pathways, offering innovative approaches to treatment.
Cancer treatment: Cancer treatment refers to the various medical interventions and therapies used to manage and combat cancer, which includes surgical procedures, chemotherapy, radiation therapy, immunotherapy, and targeted therapies. These approaches aim to eliminate cancer cells, shrink tumors, alleviate symptoms, and improve overall survival rates. The evolution of cancer treatment has been significantly influenced by advancements in immune engineering and synthetic immunology, leading to more personalized and effective therapies that harness the body's immune system to fight cancer.
CAR T-cell therapy: CAR T-cell therapy is an innovative cancer treatment that involves modifying a patient's own T-cells to express chimeric antigen receptors (CARs) that specifically target and kill cancer cells. This personalized immunotherapy leverages the body's immune system to recognize and destroy tumors, making it a prime example of the intersection between advanced technology and immune engineering. By enhancing T-cell function, this therapy also addresses challenges related to tumor immune evasion and underscores the importance of tumor antigens in effective immune surveillance.
CAR-NK Cells: CAR-NK cells are genetically engineered natural killer (NK) cells that express chimeric antigen receptors (CARs) designed to enhance their ability to recognize and eliminate cancer cells. This innovative approach combines the innate immune properties of NK cells with the specificity of CAR technology, making CAR-NK cells a promising tool in cancer immunotherapy.
CAR-T Cells: CAR-T cells are genetically engineered T cells that express a chimeric antigen receptor (CAR) on their surface, allowing them to specifically target and kill cancer cells. This innovative approach represents a significant advancement in immunotherapy, providing a way to harness the body's immune system to fight malignancies more effectively by redirecting T cells against tumor-specific antigens.
Carl June: Carl June is a prominent immunologist known for his pioneering work in the field of CAR T-cell therapy, which involves engineering a patient's own T cells to better recognize and attack cancer cells. His research has played a crucial role in advancing immune engineering and synthetic immunology, leading to new therapeutic approaches for treating various cancers, particularly hematological malignancies.
Checkpoint inhibitors: Checkpoint inhibitors are a type of cancer immunotherapy that work by blocking proteins that suppress the immune system's ability to attack cancer cells. These inhibitors enhance the immune response against tumors by preventing cancer cells from evading immune detection, leading to improved patient outcomes in various cancers. They are a significant advancement in cancer treatment, highlighting the role of the immune system in combating malignancies.
Crispr-cas9: Crispr-Cas9 is a revolutionary genome editing technology that enables precise modifications to DNA within organisms. This system utilizes a guide RNA to target specific DNA sequences, while the Cas9 enzyme acts as molecular scissors to cut the DNA, allowing for the removal, addition, or alteration of genetic material. The simplicity and efficiency of this technology have transformed the fields of genetics and synthetic biology, including advancements in immune engineering.
Cytokines: Cytokines are small signaling proteins that are crucial for cell communication in the immune system. They play an essential role in mediating and regulating immunity, inflammation, and hematopoiesis, linking innate and adaptive immune responses.
Gene editing: Gene editing is a set of technologies that allow scientists to modify an organism's DNA with high precision, enabling the addition, deletion, or alteration of specific genetic material. This process has transformed the fields of genetics and biotechnology, facilitating advancements in medicine, agriculture, and research. By employing various techniques, gene editing opens the door to innovative solutions for genetic disorders and the development of engineered immune responses.
Immune checkpoint blockade: Immune checkpoint blockade refers to a therapeutic approach that inhibits checkpoint proteins from binding with their partner proteins, effectively unleashing the immune system's ability to attack cancer cells. This strategy has been pivotal in cancer immunotherapy, as it enhances the immune response against tumors by blocking inhibitory signals that prevent T cells from functioning effectively. The growing use of immune checkpoint inhibitors has transformed cancer treatment and underscores the importance of understanding immune regulation in therapeutic contexts.
Monoclonal antibodies: Monoclonal antibodies are laboratory-produced molecules engineered to bind specifically to target antigens, such as proteins on the surface of cells. These antibodies are derived from a single clone of immune cells and are designed to recognize only one specific epitope, making them incredibly useful in various biomedical applications, including diagnostics, therapeutics, and research.
Nanotechnology: Nanotechnology is the manipulation of matter on an atomic or molecular scale, typically within the range of 1 to 100 nanometers. This technology allows for the creation of new materials and devices with unique properties, enabling innovative applications in various fields including medicine, electronics, and materials science. In the context of immune engineering and synthetic immunology, nanotechnology offers potential advancements in targeted drug delivery, vaccine development, and the design of biomaterials that can interact specifically with immune cells.
Nk cell engagers: NK cell engagers are biopharmaceutical agents designed to stimulate and enhance the activity of natural killer (NK) cells, which are crucial components of the innate immune system responsible for targeting and eliminating infected or malignant cells. By bridging NK cells with target cells, these engagers can promote the cytotoxic effects of NK cells and improve the body’s ability to fight cancer and viral infections.
Synthetic receptors: Synthetic receptors are engineered molecules designed to mimic the natural receptors found in biological systems. These artificial constructs are created to interact with specific ligands or signals, enabling researchers and scientists to manipulate immune responses or other biological functions in a precise manner. They play a crucial role in the field of immune engineering and synthetic immunology by providing innovative approaches to modulate immune activity and develop novel therapeutic strategies.
T-cell engineering: T-cell engineering is the process of modifying T cells to enhance their ability to target and eliminate specific cells, particularly in the context of cancer and infectious diseases. This approach involves the use of genetic modification techniques, such as CRISPR or viral vectors, to introduce new receptors or enhance the functionality of T cells, allowing them to better recognize and attack diseased cells while preserving healthy tissues.
Tcr-engineered t cells: TCR-engineered T cells are T cells that have been genetically modified to express a specific T-cell receptor (TCR) that targets a particular antigen on tumor cells or infected cells. This engineering enhances the T cells' ability to recognize and eliminate cells expressing the targeted antigen, which is a crucial aspect of immune engineering and synthetic immunology as it aims to create tailored immune responses against diseases like cancer.
Zelig Eshhar: Zelig Eshhar is a prominent figure in the fields of synthetic immunology and immune engineering, known for his contributions to the development of engineered immune responses and synthetic biology applications in immunotherapy. His work focuses on creating tailored immune responses through innovative techniques that enhance the body's ability to fight diseases such as cancer and autoimmune disorders. Eshhar's research emphasizes the integration of genetic engineering, cell therapy, and immunomodulation to design more effective therapeutic strategies.